CNA Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-250,000
| Closed | -$14.5M | – | 17 |
|
|
2023
Q3 | $14.5M | Buy |
250,000
+65,000
| +35% | +$3.77M | 8.14% | 6 |
|
|
2023
Q2 | $11.8M | Buy |
185,000
+10,000
| +6% | +$640K | 7.11% | 6 |
|
|
2023
Q1 | $12.1M | Buy |
175,000
+5,000
| +3% | +$347K | 7.32% | 5 |
|
|
2022
Q4 | $12.2M | Hold |
170,000
| – | – | 7.44% | 4 |
|
|
2022
Q3 | $12.1M | Sell |
170,000
-11,000
| -6% | -$782K | 4.6% | 5 |
|
|
2022
Q2 | $13.9M | Buy |
181,000
+6,000
| +3% | +$462K | 4.87% | 3 |
|
|
2022
Q1 | $12.8M | Sell |
175,000
-15,000
| -8% | -$1.1M | 3.96% | 2 |
|
|
2021
Q4 | $11.8M | Buy |
190,000
+30,000
| +19% | +$1.87M | 3.1% | 2 |
|
|
2021
Q3 | $9.47M | Buy |
160,000
+25,000
| +19% | +$1.48M | 2.58% | 4 |
|
|
2021
Q2 | $9.02M | Sell |
135,000
-10,000
| -7% | -$668K | 2.55% | 4 |
|
|
2021
Q1 | $9.15M | Buy |
145,000
+25,000
| +21% | +$1.58M | 2.81% | 3 |
|
|
2020
Q4 | $7.44M | Sell |
120,000
-5,000
| -4% | -$310K | 2.34% | 5 |
|
|
2020
Q3 | $7.54M | Hold |
125,000
| – | – | 2.77% | 4 |
|
|
2020
Q2 | $7.35M | Sell |
125,000
-75,000
| -38% | -$4.41M | 2.91% | 3 |
|
|
2020
Q1 | $11.1M | Buy |
200,000
+90,000
| +82% | +$5.02M | 4.7% | 3 |
|
|
2019
Q4 | $7.06M | Sell |
110,000
-55,000
| -33% | -$3.53M | 1.9% | 11 |
|
|
2019
Q3 | $8.37M | Buy |
165,000
+55,000
| +50% | +$2.79M | 1.87% | 8 |
|
|
2019
Q2 | $4.99M | Buy |
+110,000
| New | +$4.99M | 1.04% | 26 |
|